Ranjeny Thomas — ASN Events
  1. Schedule
  2. Ranjeny Thomas

Ranjeny Thomas

University of Queensland, QLD, Australia

  • This delegate is presenting an abstract at this event.
Professor Thomas is Professor of Rheumatology at University of Queensland, Translational Research Institute, consultant rheumatologist at Princess Alexandra Hospital, fellow of the Australian Academy of Health and Medical Sciences and member of the Order of Australia. She has founded two spin-off companies Dendright (2006-2021), and Liperate in 2022. Liperate recently opened a trial of a liposome-based tolerance immunotherapy for type 1 diabetes. Ranjeny and her team were recently awarded a MRFF Frontiers grant towards the moonshot goal of a cure for rheumatoid arthritis.
Presentations this author is a contributor to:

ChgA-specific liposome treatment of NOD mice prevents T1D progression (#120)

3:25 PM
Anne-Sophie Bergot
Workshop 10: Autoimmunity

Antigen-specific memory T cells are regulated by subcutaneous administration of liposomes encapsulating calcitriol and peptide antigen (#218)

4:00 PM
Ryan Galea
Poster Session One & Burnet Oration Cocktail Function

Impaired control of autoreactive T Cell expansion is associated with pype-1 regulatory T Cell deficiency in BALB/c ZAP70W163C mutant mice (#421)

4:00 PM
M Arifur Rahman
Poster Session Three

Eliciting innate and adaptive anti-tumour immunity by nanoemulsion co-delivery of tumour antigen and nkt cell ligand to cd8α+ dcs (#287)

4:00 PM
Pui Yeng Lam
Poster Session Two

Liposomal delivered antigen-specific tolerising immunotherapy targeting autoreactive CD8+ T cells in NOD mice (#173)

4:00 PM
Irina Buckle
Poster Session One & Burnet Oration Cocktail Function